It should be noted that previous studies have reported CTC positivity rates of over 75% by using ISET in advanced NSCLC [23,29,33,52] however in these studies, CTC identification was based on cytomorphological criteria assessed by Giemsa staining and/or CD45 negativity. This evidence concerns the gene PTPRC and non-small cell lung carcinoma.